Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III)

  1. Sferra, T.J.
  2. Merta, T.
  3. Neely, M.
  4. Murta De Oliveira, C.
  5. Lassaletta, A.
  6. Fortuny Guasch, C.
  7. Dorr, M.B.
  8. Winchell, G.
  9. Su, F.-H.
  10. Perko, S.
  11. Fernsler, D.
  12. Waskin, H.
  13. Holden, S.R.
Revue:
Journal of the Pediatric Infectious Diseases Society

ISSN: 2048-7207,  2048-7193

Année de publication: 2023

Volumen: 12

Número: 6

Pages: 334-341

Type: Article

DOI: 10.1093/JPIDS/PIAD031 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus